Enferplex Bovine TB Test approved by OIE

The Enferplex Bovine TB Antibody test has been approved by the World Organisation for Animal Health (OIE) in June 2019, for the following uses: Certified by the OIE as fit for the detection of antibody to Mycobacterium bovis in cattle serum samples, to be used as an ancillary test in conjunction with other methods for serological prevalence surveys, or diagnosis and management of M. bovis infection within herds, for the following purposes:”

• To confirm, but not negate, diagnosis of suspect or clinical cases, including confirmation of positive screening tests in individual animals and in herds with infection prevalence ranging from very low to high.
• To detect M. bovis infected animals not positive by Single Intradermal Comparative Cervical Tuberculin or Interferon Gamma tests.
• To confirm, but not negate, infection in animals giving inconclusive reactions in the SICCT.
• To identify animals most likely to have visible lesions (VL) by scoring the number of M. bovis antigens recognised by seropositive Bovine TB-infected animals.

We are currently in discussion with the UK and Irish Governments as to how the test may be used for the detection and control of bovine TB. For the time being the use of the test is still be restricted by the UK Government to herds under Tb restriction where the gamma-interferon test has been used. We hope that these restrictions will be lifted soon.   Register of diagnostic kits certified by the OIE as validated as fit for purpose Registration Number 20190113